Abstract
Background
The early diagnosis of acute myocardial infarction (AMI) in patients with mild elevations of high-sensitivity cardiac troponin (hs-cTn) is a challenge. It is unclear whether copeptin, a marker of endogenous stress, or 1h-hs-cTn changes are better suited to address this important unmet clinical need.
Methods
We prospectively enrolled patients presenting with symptoms suggestive of AMI to the emergency department (ED). Two independent cardiologists adjudicated the final diagnosis. Mild hs-cTn elevations were defined as 26.2 ng/L (99th percentile) to 75 ng/L for hs-cTnI, and 14 ng/L (99th percentile) to 50 ng/L (biological-equivalent to 75 ng/L for hs-cTnI) for hs-cTnT.
Results
Among 1356 patients, 80 (6%) had mild hs-cTnI elevations at presentation. Within this group, AMI was the final diagnosis in 39 patients (49%). The diagnostic accuracy for the diagnosis of AMI as quantified by the area under the receiver operating characteristic curve (AUC) was 0.51 (95% CI 0.39–0.64) for hs-cTnI at presentation, 0.58 (95% CI 0.45–0.71) for copeptin at presentation, and 0.78 (95% CI 0.68–0.88) for 1h-hs-cTnI changes, which was significantly higher as compared to copeptin (p = 0.02) or hs-cTnI alone (p < 0.001). The additional use of 1h-hs-cTnI changes, but not of copeptin, improved diagnostic accuracy of hs-cTnI at presentation (AUC 0.80, 95% CI 0.70–0.90; p = 0.002 for comparison). Similar findings regarding copeptin and 1h-hs-cTnT/I changes were obtained for mild hs-cTnT elevations.
Conclusions
About 6–22% of patients presenting with suggestive AMI to the ED have mild hs-cTnT/I elevations at presentation. In contrast to copeptin, the addition of 1h-hs-cTn changes substantially improves the early diagnosis of AMI.
Similar content being viewed by others
References
Pitts SR, Niska RW, Xu J, Burt CW (2008) National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary. Natl Health Stat Report 1–38
Thygesen K, Alpert JS, White HD (2007) Universal definition of myocardial infarction. Eur Heart J 28:2525–2538. doi:10.1093/eurheartj/ehm355
Roffi M, Patrono C, Collet J-P et al (2015) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J ehv320. doi:10.1093/eurheartj/ehv320
Thygesen K, Mair J, Giannitsis E et al (2012) How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 33:2252–2257. doi:10.1093/eurheartj/ehs154
Giannitsis E, Kurz K, Hallermayer K et al (2010) Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 56:254–261. doi:10.1373/clinchem.2009.132654
Reichlin T, Hochholzer W, Bassetti S et al (2009) Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 361:858–867. doi:10.1056/NEJMoa0900428
Keller T, Zeller T, Peetz D et al (2009) Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 361:868–877. doi:10.1056/NEJMoa0903515
Mueller C (2014) Biomarkers and acute coronary syndromes: an update. Eur Heart J 35:552–556. doi:10.1093/eurheartj/eht530
Wang K, Asinger RW, Marriott HJL (2003) ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 349:2128–2135
Reichlin T, Hochholzer W, Stelzig C et al (2009) Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 54:60–68. doi:10.1016/j.jacc.2009.01.076
Holwerda DA (1972) A glycopeptide from the posterior lobe of pig pituitaries. I. Isolation and characterization. Eur J Biochem 28:334–339
Struck J, Morgenthaler NG, Bergmann A (2005) Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides 26:2500–2504. doi:10.1016/j.peptides.2005.04.019
Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:112–119. doi:10.1373/clinchem.2005.060038
Keller T, Tzikas S, Zeller T et al (2010) Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 55:2096–2106. doi:10.1016/j.jacc.2010.01.029
Lipinski MJ, Escárcega RO, D’Ascenzo F et al (2014) A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction. Am J Cardiol 113:1581–1591. doi:10.1016/j.amjcard.2014.01.436
Raskovalova T, Twerenbold R, Collinson PO et al (2014) Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care 3:18–27. doi:10.1177/2048872613514015
Wildi K, Zellweger C, Twerenbold R et al (2015) Incremental value of copeptin to highly sensitive cardiac troponin I for rapid rule-out of myocardial infarction. Int J Cardiol 190:170–176. doi:10.1016/j.ijcard.2015.04.133
Stallone F, Schoenenberger AW, Puelacher C et al (2016) Incremental value of copeptin in suspected acute myocardial infarction very early after symptom onset. Eur Heart J Acute Cardiovasc Care. doi:10.1177/2048872616641289
Reichlin T, Schindler C, Drexler B et al (2012) One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 172:1211–1218. doi:10.1001/archinternmed.2012.3698
Rubini Gimenez M, Twerenbold R, Jaeger C et al (2015) One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am J Med. doi:10.1016/j.amjmed.2015.01.046
Reichlin T, Cullen L, Parsonage W a et al (2014) Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Am J Med. doi:10.1016/j.amjmed.2014.10.032
Reichlin T, Irfan A, Twerenbold R et al (2011) Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 124:136–145. doi:10.1161/CIRCULATIONAHA.111.023937
Boeddinghaus J, Reichlin T, Cullen L et al (2016) Two-hour algorithm for triage toward rule-out and rule-in of acute myocardial infarction by use of high-sensitivity cardiac troponin I. Clin Chem 62:494–504. doi:10.1373/clinchem.2015.249508
Apple FS, Ler R, Murakami MM (2012) Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 58:1574–1581. doi:10.1373/clinchem.2012.192716
Koerbin G, Tate J, Potter JM et al (2012) Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population. Clin Chem Lab Med 50:871–878. doi:10.1515/cclm-2011-0540
Krintus M, Kozinski M, Boudry P et al (2014) European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay. Clin Chem Lab Med 52:1657–1665. doi:10.1515/cclm-2014-0107
Wildi K, Rubini Gimenez M, Twerenbold R et al (2015) Misdiagnosis of myocardial infarction related to limitations of the current regulatory approach to define clinical decision values for cardiac troponin. Circulation. doi:10.1161/CIRCULATIONAHA.114.014129
Levey AS, Coresh J, Greene T et al (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254
Björk J, Forberg JL, Ohlsson M et al (2006) A simple statistical model for prediction of acute coronary syndrome in chest pain patients in the emergency department. BMC Med Inform Decis Making 6:28. doi:10.1186/1472-6947-6-28
Apple FS, Jesse RL, Newby LK et al (2007) National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Circulation 115:e352–e355. doi:10.1161/CIRCULATIONAHA.107.182881
DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845
Ukena C, Kindermann M, Mahfoud F et al (2014) Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis. Clin Res Cardiol 103:743–751. doi:10.1007/s00392-014-0709-z
Albarqouni L, von Eisenhart Rothe A, Ronel J et al (2016) Frequency and covariates of fear of death during myocardial infarction and its impact on prehospital delay: findings from the multicentre MEDEA Study. Clin Res Cardiol 105:135–144. doi:10.1007/s00392-015-0895-3
Ferrari M, Kruzliak P, Spiliopoulos K (2015) An insight into short- and long-term mechanical circulatory support systems. Clin Res Cardiol 104:95–111. doi:10.1007/s00392-014-0771-6
Härle T, Zeymer U, Hochadel M et al (2015) Use and impact of thrombectomy in primary percutaneous coronary intervention for acute myocardial infarction with persistent ST-segment elevation: results of the prospective ALKK PCI-registry. Clin Res Cardiol 104:803–811. doi:10.1007/s00392-015-0846-z
Amann U, Kirchberger I, Heier M et al (2014) Long-term survival in patients with different combinations of evidence-based medications after incident acute myocardial infarction: results from the MONICA/KORA Myocardial Infarction Registry. Clin Res Cardiol 103:655–664. doi:10.1007/s00392-014-0688-0
Jung C, Fuernau G, de Waha S et al (2015) Intraaortic balloon counterpulsation and microcirculation in cardiogenic shock complicating myocardial infarction: an IABP-SHOCK II substudy. Clin Res Cardiol 104:679–687. doi:10.1007/s00392-015-0833-4
Sinning C, Kieback A, Wild PS et al (2014) Association of multiple biomarkers and classical risk factors with early carotid atherosclerosis: results from the Gutenberg Health Study. Clin Res Cardiol 103:477–485. doi:10.1007/s00392-014-0674-6
Fengler K, Fuernau G, Desch S et al (2015) Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial. Clin Res Cardiol 104:71–78. doi:10.1007/s00392-014-0767-2
Del Rosario Espinoza Mora M, Böhm M, Link A (2014) The Th17/Treg imbalance in patients with cardiogenic shock. Clin Res Cardiol 103:301–313. doi:10.1007/s00392-013-0656-0
Härle T, Zeymer U, Schwarz AK et al (2014) Use of drug-eluting stents in acute myocardial infarction with persistent ST-segment elevation: results of the ALKK PCI-registry. Clin Res Cardiol 103:373–380. doi:10.1007/s00392-014-0664-8
Fichtner S, Senges J, Hochadel M et al (2016) Safety and efficacy in ablation of premature ventricular contraction: data from the German ablation registry. Clin Res Cardiol. doi:10.1007/s00392-016-1022-9
Fuernau G, Fengler K, Desch S et al (2016) Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial. Clin Res Cardiol 105:1030–1041. doi:10.1007/s00392-016-1017-6
Schuster A, Faulkner M, Zeymer U et al (2015) Economic implications of intra-aortic balloon support for myocardial infarction with cardiogenic shock: an analysis from the IABP-SHOCK II-trial. Clin Res Cardiol 104:566–573. doi:10.1007/s00392-015-0819-2
Giavarina D, Carta M, Fortunato A et al (2011) Copeptin and high sensitive troponin for a rapid rule out of acute myocardial infarction? Clin Lab 57:725–730
Jaeger C, Wildi K, Twerenbold R et al (2016) One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am Heart J 171(92–102):e5. doi:10.1016/j.ahj.2015.07.022
Nestelberger T, Wildi K, Boeddinghaus J et al (2016) Characterization of the observe zone of the ESC 2015 high-sensitivity cardiac troponin 0h/1h-algorithm for the early diagnosis of acute myocardial infarction. Int J Cardiol 207:238–245. doi:10.1016/j.ijcard.2016.01.112
Möckel M, Searle J, Hamm C, et al (2014) Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J 369–376. doi:10.1093/eurheartj/ehu178
Haaf P, Reichlin T, Twerenbold R et al (2014) Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. Eur Heart J 35:365–375. doi:10.1093/eurheartj/eht218
Rubini Gimenez M, Twerenbold R, Reichlin T et al (2014) Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. Eur Heart J 35:2303–2311. doi:10.1093/eurheartj/ehu188
Acknowledgements
We are indebted to the patients who participated in the study and to the emergency department staff as well as the laboratory technicians of all participating sites for their most valuable efforts. In addition, we wish to thank Claudia Stelzig, MS, Kathrin Meissner, RN, Michael Freese, RN, Melanie Wieland, RN, Irina Klimmeck, RN, Fausta Chiaverio, RN (all University Hospital Basel, Switzerland), Esther Garrido, MD, Isabel Campodarve, MD, Joachim Gea, MD (Hospital del Mar, IMIM, Barcelona, Spain), Helena Mañé Cruz, NR Carolina Isabel Fuenzalida Inostroza, NR (Hospital Clinic, Barcelona, Spain), and Miguel Angel García Briñón, NR (Hospital Clínico San Carlos, Madrid, Spain). The study was supported by research grants from the Swiss National Science Foundation, the European Union, the Swiss Heart Foundation, Abbott, Beckman Coulter, BRAHMS, Roche, Siemens, 8sense, Nanosphere, Alere and the Department of Internal Medicine, University Hospital Basel.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors designed the study, gathered, and analyzed the data, vouched for the data and analysis, wrote the paper, and decided to publish. Drs. Boeddinghaus, Reichlin, and Mueller had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. All authors have read and approved the manuscript. The sponsors had no role in designing or conducting the study and no role in gathering or analyzing the data or writing the manuscript. The manuscript and its contents have not been published previously and are not being considered for publications elsewhere in whole or in part in any language, including publicly accessible web sites or e-print servers. We disclose that Dr. Mueller has received research support from the Swiss National Science Foundation, the Swiss Heart Foundation, Abbott, Alere, Brahms, Nanosphere, Roche, Siemens, 8sense, Nanosphere, and the Department of Internal Medicine, University Hospital Basel, as well as speaker honoraria from Abbott, Alere, Brahms, Novartis, Roche, and Siemens. Dr. Reichlin has received research grants from the Goldschmidt-Jacobson-Foundation, the Swiss National Science Foundation (PASMP3-136995), the Swiss Heart Foundation, the Professor Max Cloëtta Foundation, the Uniscientia Foundation Vaduz, the University of Basel and the Department of Internal Medicine, University Hospital Basel as well as speaker honoraria from Brahms and Roche. Dr. Rubini received speakers honoraria from Abbott. All other authors declare that they have no conflict of interest with this study.
Additional information
J. Boeddinghaus and T. Reichlin contributed equally to this manuscript and should be considered first author.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Boeddinghaus, J., Reichlin, T., Nestelberger, T. et al. Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin. Clin Res Cardiol 106, 457–467 (2017). https://doi.org/10.1007/s00392-016-1075-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-016-1075-9